Correlation Between Preoperative NT-proBNP and Postoperative AKI - Trial NCT06145347
Access comprehensive clinical trial information for NCT06145347 through Pure Global AI's free database. This phase not specified trial is sponsored by Xijing Hospital and is currently Recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 633 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Xijing Hospital
Timeline & Enrollment
N/A
Jul 10, 2023
Jan 31, 2024
Primary Outcome
Incidence of AKI assessed by KDIGO 2012 (Kidney Disease: Improving Global Outcomes)
Summary
Accurate preoperative AKI risk prediction is of great significance for improving patient
 outcomes. The use of preoperative NT-proBNP can provide a more precise assessment of the
 body's fluid load status, guide intraoperative and postoperative fluid management, and thus
 reduce fluid related postoperative complications. Given the potential association between
 ERAS and increased postoperative AKI, we hypothesize that preoperative NT-proBNP may be
 associated with the development of postoperative AKI in ERAS, and can improve the prediction
 of AKI beyond traditional clinical risk factors. This study aims to validate this hypothesis
 and provide evidence for using NT-proBNP to assess AKI risk before non cardiac surgery.
 Improve the predictive ability of clinical predictive models and optimize ERAS protocols to
 prevent postoperative AKI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06145347
Non-Device Trial